

28 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ut-health-san-antonio-research-shows-alzheimers-prevention-potential-in-pairing-cannabis-ingredient-anti-inflammatory-drug-302673222.html

20 Jan 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/first-of-its-kind-medical-grade-cannabis-pharmacy-launches-in-colorado-302665539.html

12 Jan 2026
// PR NEWSWIRE BIO
https://www.prnewswire.com/news-releases/mandara-biopharma-files-ind-with-the-fda-to-advance-dronabinol-oral-solution-formulation-for-alzheimers-agitation-302658358.html

22 Sep 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/igc-pharma-reports-50-patient-enrollment-milestone-in-phase-2-calma-alzheimers-agitat-1076002

13 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/benuvia-operations-signs-commercial-supply-agreement-with-leading-us-pharmaceutical-company-for-dronabinol-api-302453302.html

10 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/benuvia-operations-llc-enters-into-licensing-agreement-with-avernus-pharma-for-syndros-cii-dronabinol-in-the-gulf-cooperation-council-region-302327491.html